IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: ...
IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: ...
Source: pr-inside.com
Page 2 - Trial Evaluating News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trial Evaluating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trial Evaluating Today - Breaking & Trending Today
IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: 18th International Conference
GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present two...
Source: pharmiweb.com
Biweekly Lower-Dose Cabazitaxel for mCRPC an Option for Older Patients
Data from the randomized phase 3 CABASTY trial “may be practice changing, especially in patients 65 years or older with mCRPC who are often denied chemotherapy in daily clinical routines,” investigators concluded. Lower-dose cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC) lowers risks for older patients.
Source: renalandurologynews.com
HU6 Reduces Liver Fat, Body Weight in Patients with NAFLD with High BMI
Compared to placebo, patients using once-daily oral HU6 100 mg, HU6 300 mg, and HU6 450 mg experienced significant changes in liver fat, volume, and whole-body adiposity after 61 days of treatment.
Source: hcplive.com
Arcutis Announces Successful Phase 3 Results for Roflumilast Cream 0.05% in Children with Atopic Dermatitis
This new data results from the pivotal INTEGUMENT-PED trial and met both its primary and secondary endpoints.
Source: hcplive.com